Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 49.97 | 29.00 |
| PEG Ratio (TTM) | 2.25 | 1.71 |
| P/S Ratio (TTM) | 1.19 | 2.33 |
| P/B Ratio (TTM) | 2.90 | 2.87 |
| P/FCF Ratio (TTM) | -21.40 | 16.15 |
| Price to 5YR AVG Earnings Ratio | N/A | 9.52 |
| Price to 5YR AVG FCF Ratio | N/A | 46.13 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.44% | 7.07% |
| ROE (TTM) | 5.91% | 12.60% |
| Net Profit Margin (TTM) | 2.33% | 7.96% |
| ROIC 5YR AVG | 9.78% | 10.94% |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 151.52% | 633.91% | 395.05% |
| Revenue | 3.62% | 8.50% | 7.58% |
| Net Income | 146.71% | 804.15% | 490.92% |
| Cash Flow | 93.65% | 817.41% | 1,030.63% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.57 | 2.35 |
| Quick Ratio (TTM) | 1.53 | 2.29 |
| D/E Ratio (TTM) | N/A | 0.31 |
| Interest Coverage (TTM) | 6.24 | 18.50 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 1.55 | 4.79 |
| LTL to 5YR AVG FCF | 51.57 | 5.83 |
| Shares Outstanding Growth 5YR AVG | 4.59% | 1.49% |